Astragalus Mongholicus Polysaccharides Alleviate Kidney Injury in Rats with Type 2 Diabetes Through Modulation of Oxidation, Inflammation, and Gut Microbiota
Open Access
- 10 February 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (4) , 1470
Abstract
We aimed to uncover the underlying mechanisms contributing to the therapeutic efficacy of Astragalus mongholicus Polysaccharides (mAPS) in alleviating diabetic nephropathy (DN). The rat model of DN was subjected to a high-sugar and high-fat diet (HSHFD) coupled with streptozotocin (STZ) injection. Our findings revealed that mAPS administration decreased fasting blood glucose (FBG), BUN, SCR, UA, and MDA levels, while elevating serum GSH, GSH-PX, and SOD activities in DN rats (p < 0.05). Furthermore, there was a notable rise in the mRNA and protein expression of renal Nrf-2, GCLC, NQO1, and HO-1 post mAPS treatment (p < 0.05). Additionally, mAPS supplementation led to reduced protein expression of TLR4, NLRP3, p-NF-κB, TGF-β, and Smad4. Concurrently, mAPS exerted a modulatory effect on gut microbiota, as evidenced by the increased abundance of Muribaculaceae, Ruminococcus_1, Phascolarctobacterium, and Lachnoclostridium-related genera. Spearman correlation analysis illustrated a negative association between the abundance of microbiota (Muribaculaceae, Lachnospiraceae_NK4A136, Ruminococcus_1, Clostridiales) and the levels of serum parameters (BUN, CR, UA, TC, TG). In summary, our data robustly attests to the potential of mAPS in modulating oxidative stress, inflammation, and gut microbiota, ultimately resulting in improved renal function in DN rats.Keywords
Funding Information
- National Natural Science Foundation of China (82160776, NMGIRT2219, 2023LHMS08074, 2023YFDZ0029, BR231404)
- Inner Mongolia Innovation Team Development Program (82160776, NMGIRT2219, 2023LHMS08074, 2023YFDZ0029, BR231404)
- Natural Science Foundation of Inner Mongolia Autonomous Region (82160776, NMGIRT2219, 2023LHMS08074, 2023YFDZ0029, BR231404)
- Science and technology programs of Inner Mongolia (82160776, NMGIRT2219, 2023LHMS08074, 2023YFDZ0029, BR231404)
- Basic scientific research business of colleges and universities directly under the Inner Mongolia Autonomous Region (82160776, NMGIRT2219, 2023LHMS08074, 2023YFDZ0029, BR231404)
This publication has 57 references indexed in Scilit:
- Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future PerspectiveJournal of Diabetes Research, 2017
- Protective effect of berberine on renal fibrosis caused by diabetic nephropathyMolecular Medicine Reports, 2017
- Perspectives of the Nrf-2 signaling pathway in cancer progression and therapyToxicology Reports, 2017
- What can target kidney fibrosis?Nephrology Dialysis Transplantation, 2017
- Diabetic nephropathy as the cause of end-stage kidney disease reported on the medical evidence form CMS2728 at a single centerClinical Kidney Journal, 2016
- TGF-β-induced differentiation into myofibroblasts involves specific regulation of two MKL1 isoformsJournal of Cell Science, 2014
- Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylationNature, 2011
- Oxidative Stress in Diabetic NephropathyCurrent Medicinal Chemistry, 2010
- Regulation on maturation and function of dendritic cells by Astragalus mongholicus polysaccharidesInternational Immunopharmacology, 2006
- Angiotensin-Converting Enzyme Inhibitors in Diabetic NephropathyAnnals of Pharmacotherapy, 1993